As of 2025-06-12, the Relative Valuation of Biogen Inc (BIIB) is 185.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 133.06 USD, the upside of Biogen Inc based on Relative Valuation is 39.5%.
The range of the Relative Valuation is 139.08 - 241.82 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 21.0x | 18.6x |
| Forward P/E multiples | 11.9x - 20.8x | 15.8x |
| Fair Price | 139.08 - 241.82 | 185.62 |
| Upside | 4.5% - 81.7% | 39.5% |
| Date | P/E |
| 2025-06-11 | 13.18 |
| 2025-06-10 | 13.42 |
| 2025-06-09 | 13.29 |
| 2025-06-06 | 13.19 |
| 2025-06-05 | 12.91 |
| 2025-06-04 | 13.06 |
| 2025-06-03 | 13.06 |
| 2025-06-02 | 12.99 |
| 2025-05-30 | 12.86 |
| 2025-05-29 | 13.15 |
| 2025-05-28 | 12.63 |
| 2025-05-27 | 12.72 |
| 2025-05-23 | 12.46 |
| 2025-05-22 | 12.51 |
| 2025-05-21 | 12.56 |
| 2025-05-20 | 12.93 |
| 2025-05-19 | 12.82 |
| 2025-05-16 | 12.44 |
| 2025-05-15 | 12.25 |
| 2025-05-14 | 11.92 |
| 2025-05-13 | 12.20 |
| 2025-05-12 | 12.32 |
| 2025-05-09 | 11.71 |
| 2025-05-08 | 11.73 |
| 2025-05-07 | 11.61 |
| 2025-05-06 | 11.57 |
| 2025-05-05 | 12.06 |
| 2025-05-02 | 12.24 |
| 2025-05-01 | 11.98 |
| 2025-04-30 | 11.99 |
| 2025-04-29 | 11.90 |
| 2025-04-28 | 11.80 |
| 2025-04-25 | 11.77 |
| 2025-04-24 | 11.84 |
| 2025-04-23 | 11.71 |
| 2025-04-22 | 11.78 |
| 2025-04-21 | 11.54 |
| 2025-04-17 | 11.75 |
| 2025-04-16 | 11.42 |
| 2025-04-15 | 11.59 |
| 2025-04-14 | 11.81 |
| 2025-04-11 | 11.41 |
| 2025-04-10 | 11.23 |
| 2025-04-09 | 11.93 |
| 2025-04-08 | 11.30 |
| 2025-04-07 | 11.81 |
| 2025-04-04 | 12.18 |
| 2025-04-03 | 12.95 |
| 2025-04-02 | 13.01 |
| 2025-04-01 | 13.08 |